<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fifteen <z:chebi fb="77" ids="46793">PEG</z:chebi>-scutellarin <z:chebi fb="0" ids="50266">prodrugs</z:chebi> were synthesized by modifying carboxyl and phenolic <z:chebi fb="10" ids="29191">hydroxyl</z:chebi> groups of scutellarin with mPEG of different molecular weight (400-3000) </plain></SENT>
<SENT sid="1" pm="."><plain>The water solubility of <z:chebi fb="0" ids="50266">prodrugs</z:chebi> increased remarkably and reached the maximum value of 783.88 mg/mL (scutellarin, 0.02 mg/mL) </plain></SENT>
<SENT sid="2" pm="."><plain>The anti-<z:mpath ids='MPATH_124'>infarct</z:mpath> effects of four <z:chebi fb="77" ids="46793">PEG</z:chebi> <z:chebi fb="0" ids="50266">prodrugs</z:chebi> with high water solubility were evaluated by <z:hpo ids='HP_0002637'>Cerebral Ischemia</z:hpo>/Reperfusion in the Middle Cerebral <z:mp ids='MP_0006134'>Artery Occlusion</z:mp> (MCAO) model </plain></SENT>
<SENT sid="3" pm="."><plain>The results showed that the <z:chebi fb="0" ids="50266">prodrug</z:chebi> 7e could significantly reduce the <z:mpath ids='MPATH_124'>infarct</z:mpath> area from 27.2% to 12.2% (33.3% for the control) and decrease the neurological deficit score from 2.77 to 1.32 (2.85 for the control) </plain></SENT>
<SENT sid="4" pm="."><plain>The half-life (18.62 min) of the <z:chebi fb="0" ids="50266">prodrug</z:chebi> 7e was significantly longer than that of scutellarin (3.03 min) </plain></SENT>
</text></document>